Skip to content

Medtronic

US · MDT #176 by market cap Listed 1970
99.94 -0.67 -0.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/11/10
  • Leerink Partners Maintains Medtronic(MDT.US) With Buy Rating, Announces Target Price $117
    Market Newswire · 2026/11/19
  • Rating change
    William Blair Maintains Medtronic(MDT.US) With Buy Rating
    Market Newswire · 2026/9/11
  • Rating change
    J.P. Morgan Maintains Medtronic(MDT.US) With Hold Rating
    Market Newswire · 2026/10/16
  • Company notice
    Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
    SEC · 2026/7/10
  • Rating change
    TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
    Market Newswire · 2026/9/30
  • Rating change
    BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
    Market Newswire · 2026/10/30
  • Company notice
    Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Blomquist Denise L.
    SEC · 2026/9/17
  • Company notice
    Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
    SEC · 2026/6/9
  • Company notice
    Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
    SEC · 2026/5/29
  • BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $120
    Market Newswire · 2026/11/16
  • Rating change
    BTIG Maintains Medtronic(MDT.US) With Buy Rating, Cuts Target Price to $99
    Market Newswire · 2026/10/12
  • Rating change
    Needham Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $114
    Market Newswire · 2026/9/17
  • Piper Sandler Upgrades Medtronic(MDT.US) to Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/11/17
  • Rating change
    Citi Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
    Market Newswire · 2026/10/5
  • Rating change
    Medtronic shares rose as Morgan Stanley initiated coverage with an "Overweight" rating, citing confidence in the value of the company's platform-based business model.
    Zhitong Finance · 2026/10/21
  • Company notice
    Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Blomquist Denise L.
    SEC · 2026/6/9
  • BTIG Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $109
    Market Newswire · 2026/11/19
  • Rating change
    Barclays Downgrades Medtronic(MDT.US) to Hold Rating, Cuts Target Price to $95
    Market Newswire · 2026/10/8
  • Rating change
    RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $118
    Market Newswire · 2026/10/3
  • Form 144 | Medtronic(MDT.US) Officer Proposes to Sell 4.75 Million in Common Stocks
    Market Newswire · 2026/10/15
  • Rating change
    Wells Fargo Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $104
    Market Newswire · 2026/9/10
  • Medtronic(MDT.US) Officer Sells US$4.75 Million in Common Stock
    Market Newswire · 2026/10/17
  • Rating change
    UBS Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $110
    Market Newswire · 2026/9/3
  • Rating change
    J.P. Morgan Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $96
    Market Newswire · 2026/9/4

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Medtronic discussion 0 comments

Add a comment